Adsorptive membranes for trapping viruses

US9375499B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9375499-B2
Application numberUS-77677407-A
CountryUS
Kind codeB2
Filing dateJul 12, 2007
Priority dateJul 14, 2006
Publication dateJun 28, 2016
Grant dateJun 28, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A disposable, virus-trapping membrane, and a corresponding method to remove viruses from solution are described. The membrane includes a disposable, micro-porous filter membrane and a ligand immobilized on the membrane. The ligand irreversibly and selectively binds viruses. The ligand also has a pKa sufficiently high to repel antibodies via electrostatic charge repulsion.

First claim

Opening claim text (preview).

What is claimed is: 1. A disposable, virus-trapping membrane comprising: a disposable, micro-porous filter membrane; and a multi-modal anion-exchange ligand immobilized on the membrane, wherein the ligand is dimensioned and configured to: (a) bind neutral viruses; (b) have a pKa sufficiently high to repel basic proteins via electrostatic charge repulsion; and (c) yield a log-reduction value (LRV) of at least 1.0 for the neutral viruses disposed in a solution comprising 50 mM salt. 2. The virus-trapping membrane of claim 1 , wherein the ligand has a positive charge at pH 7. 3. The virus-trapping membrane of claim 1 , wherein the ligand has a pKa of at least 10.0. 4. The virus-trapping membrane of claim 1 , wherein the filter membrane comprises a polymer substrate selected from the group consisting of polyvinylidene difluoride, polytetrafluorethylene, polyamides, polyamide-imides, polysulfones, polyethersulfones, and polyphenylsulfones. 5. The virus-trapping membrane of claim 1 , wherein the ligand is dimensioned and configured to yield a log-reduction value (LRV) of at least 1.0 for neutral viruses disposed in a solution comprising 150 mM salt. 6. The virus-trapping membrane of claim 1 , wherein the ligand is dimensioned and configured to yield a log-reduction value (LRV) of at least 5.0 for neutral viruses disposed in a solution comprising 50 mM salt. 7. The virus-trapping membrane of claim 1 , wherein the ligand is dimensioned and configured to yield a log-reduction value (LRV) of at least 5.0 for neutral viruses disposed in a solution comprising 150 mM salt. 8. The virus-trapping membrane of claim 1 , wherein the ligand is selected from the group consisting of tyrosinol, tryptophanol, octopamine, 2-aminobenzimidazole, 1,3-diamino-2-hydroxypropane, tris(2-aminoethyl)amine, and agmatine. 9. A disposable, virus-trapping membrane comprising: a disposable, micro-porous filter membrane; and a ligand immobilized on the membrane, wherein the ligand is selected from the group consisting of tyrosinol, tryptophanol, octopamine, 2-aminobenzimidazole, 1,3-diamino-2-hydroxypropane, tris(2-aminoethyl)amine, and agmatine, and further wherein the ligand: (a) binds neutral viruses; (b) is a multi-modal anion-exchange ligand; (c) has a pKa sufficiently high to repel basic proteins via electrostatic charge repulsion; and (d) yields a log-reduction value (LRV) of at least 1.0 for the neutral viruses disposed in a solution comprising 50 mM salt. 10. The virus-trapping membrane of claim 9 , wherein the ligand is selected from the group consisting of tryptophanol, 2-aminobenzimidazole, tris(2-aminoethyl)amine, and agmatine, and further wherein the ligand is dimensioned and configured to yield a log-reduction value (LRV) of at least 1.0 for neutral viruses disposed in a solution comprising 150 mM salt. 11. The virus-trapping membrane of claim 9 , wherein the ligand is selected from the group consisting of tris(2-aminoethyl)amine and agmatine, and further wherein the ligand is dimensioned and configured to yield a log-reduction value (LRV) of at least 5.0 for neutral viruses disposed in a solution comprising 50 mM salt. 12. The virus-trapping membrane of claim 9 , wherein the ligand is selected from the group consisting of tris(2-aminoethyl)amine and agmatine, and further wherein the ligand is dimensioned and configured to yield a log-reduction value (LRV) of at least 5.0 for neutral viruses disposed in a solution comprising 150 mM salt. 13. A method of removing viruses from a solution suspected of containing viruses, the method comprising: contacting a solution suspected of containing viruses with virus-trapping membrane comprising a disposable, micro-porous filter membrane and a multi-modal anion-exchange ligand immobilized on the membrane, wherein the ligand is dimensioned and configured to bind neutral viruses, has a pKa sufficiently high to repel basic proteins present in the solution via electrostatic charge repulsion, and yields a log-reduction value (LRV) of at least 1.0 for the neutral viruses disposed in a solution comprising 50 mM salt. 14. The method of claim 13 , wherein the solution is contacted with the virus-trapping membrane for a time sufficient to yield a log-reduction value (LRV) of at least 1.0 for neutral viruses disposed in the solution when the solution comprises from 0 to about 50 mM salt. 15. The method of claim 13 , wherein the solution is contacted with the virus-trapping membrane for a time sufficient to yield a log-reduction value (LRV) of at least 1.0 for neutral viruses disposed in the solution when the solution comprises from 0 to about 150 mM salt. 16. The method of claim 13 , wherein the solution is contacted with the virus-trapping membrane for a time sufficient to yield a log-reduction value (LRV) of at least 5.0 for neutral viruses disposed in the solution when the solution comprises from 0 to about 50 mM salt. 17. The method of claim 13 , wherein the solution is contacted with the virus-trapping membrane for a time sufficient to yield a log-reduction value (LRV) of at least 5.0 for neutral viruses disposed in the solution when the solution comprises from 0 to about 150 mM salt. 18. The method of claim 13 , wherein the solution is contacted with a disposable, micro-porous filter membrane comprising polyvinylidene difluoride; and the ligand immobilized on the membrane is selected from the group consisting of tyrosinol, tryptophanol, octopamine, 2-aminobenzimidazole, 1,3-diamino-2-hydroxypropane, tris(2-aminoethyl)amine, and agmatine. 19. The method of claim 18 , wherein the ligand immobilized on the membrane is selected from the group consisting of tris(2-aminoethyl)amine and agmatine. 20. A disposable, virus-trapping membrane comprising: a disposable, micro-porous filter membrane; a multi-modal exchange ligand immobilized on the membrane, wherein the ligand is selected from the group consisting of tryptophanol, 2-aminobenzimidazole, tris(2-aminoethyl)amine, and agmatine, and further wherein the ligand is dimensioned and configured to: (a) bind neutral viruses; (b) have a pKa sufficiently high to repel basic proteins via electrostatic charge repulsion; and (c) yield a log-reduction value (LRV) of at least 1.0 for the neutral viruses disposed in a solution comprising 150 mM salt. 21. The virus-trapping membrane of claim 20 , wherein the ligand is dimensioned and configured to yield a log-reduction value (LRV) of at least 5.0 for the neutral viruses disposed in a solution comprising 150 mM salt. 22. The virus-trapping membrane of claim 20 , wherein the ligand is selected from the group consisting of tris(2-aminoethyl)amine and agmatine, and is dimensioned and configured to yield a log-reduction value (LRV) of at least 5.0 for the neutral viruses disposed in a solution comprising 150 mM salt.

Assignees

Inventors

Classifications

  • the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such · CPC title

  • Membrane, sheet, cloth, pad, lamellar or mat · CPC title

  • being less than 2 nm, i.e. micropores or nanopores · CPC title

  • obtained by reactions only involving carbon to carbon unsaturated bonds (macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds per se C08F) · CPC title

  • Coating or impregnation layers comprising different type of functional groups or interactions, e.g. different ligands in various parts of the sorbent, mixed mode, dual zone, bimodal, multimodal, ionic or hydrophobic, cationic or anionic, hydrophilic or hydrophobic · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9375499B2 cover?
A disposable, virus-trapping membrane, and a corresponding method to remove viruses from solution are described. The membrane includes a disposable, micro-porous filter membrane and a ligand immobilized on the membrane. The ligand irreversibly and selectively binds viruses. The ligand also has a pKa sufficiently high to repel antibodies via electrostatic charge repulsion.
Who is the assignee on this patent?
Etzel Mark R, Wisconsin Alumni Res Found
What technology area does this patent fall under?
Primary CPC classification C12N7/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).